The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Priligy 30 mg film-coated tablets



A. Menarini Pharmaceuticals Ireland LtdPA1833/001/001

Main Information

Trade NamePriligy 30 mg film-coated tablets
Active SubstancesDapoxetine
Dosage FormFilm-coated tablet
Licence HolderA. Menarini Pharmaceuticals Ireland Ltd
Licence NumberPA1833/001/001

Group Information

ATC CodeG04BX Other urologicals
G04BX14 dapoxetine

Status

License statusAuthorised
Licence Issued02/03/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back